Our previous work reported the association between two single nucleotide polymorphisms (SNPs) in PIN1 promoter and nasopharyngeal carcinoma (NPC) risk with a small sample size in a low incidence area. This study investigated the association between the two SNPs and NPC risk in 733 patients and 895 controls from a high incidence area. The results indicated the genotype and allele frequencies of -842G > C and -667C > T were both significantly different between patients and controls even using the resampling statistics. The -842GC and -667TT genotypes showed a significantly increased risk of NPC (OR = 1.977, 95% CI = 1.339-2.919, P = 0.001 and OR = 1.438, 95% CI = 1.061-1.922, P = 0.019, respectively). Compared to the most common -842G-667C haplotype, -842G-667T haplotype and -842C-667C haplotype showed a significantly increased risk of NPC (OR = 1.215, 95% CI = 1.053-1.402, P = 0.008 and OR = 2.268, 95% CI = 1.530-3.362, P = 0.001, respectively). Further reporter gene expression suggested that variant -842C-667C and -842G-667T were associated with an enhanced transcriptional activity. In conclusion, our findings suggest that -842G > C and -667C > T in PIN1 promoter are associated with NPC risk; as well as the promoter activity is mediated by functional PIN1 variants.
countries, the prevalence rate of NPC is remarkably high in Southern China, especially in Guangdong Province 14, 15 . Over 95% of NPC is associated with EBV. The severity of EBV infection is related with carcinoma type: undifferentiated carcinomas have the highest EBV titers 16 . For the important role of PIN1 in EBV and multiple oncogenic signals, it is reasonable to postulate that PIN1 plays a key role in NPC. Recent study demonstrates that overexpression of PIN1 enhances cancer growth and aggressiveness in EBV-associated NPC 17 .
Our previous work indicated that two PIN1 polymorphisms were associated with the risk of NPC in a relative small sample from Hunan province, not a typical high incidence area of NPC 18 . Therefore, studies with larger population in high incidence region of NPC are needed to verify previous observation. In this study, associations between the two SNPs and the risk of NPC were evaluated in 733 patients and 895 controls from Guangdong Province, and the promoter activity that may be mediated by potentially functional PIN1 variants was assessed in NPC cells.
Results
Characteristics of the study population. A total of 733 nasopharyngeal cases and 895 controls from Guangdong province in Southern China were recruited in this study. Main characteristics of the study subjects were presented in Table 1 . There were no statistically significant differences in the distributions of age (P = 0.052) and gender (P = 0.131) between cases and controls.
Distribution of PIN1 polymorphisms and risk of nasopharyngeal carcinoma. The genotype and
allele frequency distributions of PIN1 SNPs (-842G > C, rs2233678 and -667C > T, rs2233679) in patients and controls were showed in Table 2 . The observed genotype frequencies for these two SNPs were in agreement with Hardy-Weinberg equilibrium in the control subjects (P = 0.095 for -842G > C and P = 0.058 for -667C > T, respectively).
The genotype frequencies of PIN1-842G > C and -667C > T were both significantly different between cases and controls (P = 0.001 and P = 0.048, respectively, Table 2 ). Compared to the -842GG genotype, the -842GC heterozygote was associated with a significantly increased NPC risk (OR = 1.977, 95% CI = 1.339-2.919, P = 0.001, Table 2 ), whereas the -842CC homozygote with a statistically insignificant NPC risk (OR = 2.520, 95% CI = 0.459-13.823, P = 0.287, Table 2 ); combination of -842CC and -842GC genotype with a significantly increased NPC risk (OR = 2.000, 95% CI = 1.366-2.927, P = 0.001, Table 2 ). In the -667C > T SNP, the -667TT genotype offered an increased risk of NPC compared with -667CC genotype (OR = 1.438, 95% CI = 1.061-1.922, P = 0.019, Table 2 ). Interestingly, significant differences were shown in the distribution of both -842G > C and -667C > T allele frequencies between cases and controls. The -842C allele and the -667T allele were associated with the increased risk of NPC (OR = 1.970, 95% CI = 1.367-2.838, P = 0.001 for -842C allele and OR = 1.160, 95% CI = 1.008-1.335, P = 0.038 for -667T allele, respectively, Table 2 ). Further resampling statistics using monte carlo estimation indicated consistent results with the associations between the genotype and allele frequency distributions of the two SNPs and NPC risk ( Supplementary Table S1 ).
The relationship between -842G > C and -667C > T genotypes and clinicopathological parameters were also analyzed with available data in some cases ( Supplementary Table S2 and Supplementary Table S3 ). No associations were observed between genotypes in the two SNPs and clinicopathological parameters, including age, gender, primary tumor extension, lymph node status and metastasis in patients.
PIN1 haplotypes and risk of nasopharyngeal carcinoma.
The LD analysis showed that the two polymorphisms in the promoter region were not in LD (LD for PIN1 -842G > C and PIN1 -667C > T: D′ = 0.706 and r 2 = 0.014, Fig. 1 ). We evaluated the association between the risk of nasopharyngeal carcinoma and haplotypes constructed from the two PIN1 polymorphisms (-842G > C, -677C > T). Four possible haplotypes were obtained. The distribution of haplotypes was significantly different between cases and controls (P < 0.001, Table 1 . Characteristics of nasopharyngeal carcinoma patients and controls. Table 3 ). Compared to the most common -842G-667C haplotype, -842G-667T haplotype and -842C-667C haplotype showed a significantly increased risk of nasopharyngeal carcinoma (OR = 1.215, 95% CI = 1.053-1.402, P = 0.008 and OR = 2.268, 95% CI = 1.530-3.362, P = 0.001, respectively, Table 3 ); -842C-667T haplotype with a statistically insignificant NPC risk (OR = 1.361, 95% CI = 0.475-3.896, P = 0.565, Table 3 ). Since the sample size for -842C-667T haplotype was small, power calculation was performed for the specific statistical analysis. The result indicated a small power (8.9%) and the association analysis should be considered as inconclusive at this point. Larger sample size is needed to make a conclusion.
Promoter activity of PIN1 polymorphisms. Four luciferase reporter gene constructs (-842G-667C,
-842G-667T, -842C-667C and -842C-667T) were generated. The luciferase activity indicated that reporter gene expression driven by the variant -842C-667C and -842G-667T were both significantly higher than those driven by the wildtype -842G-667C (2.15 fold higher for -842C-667C, and 1.40 fold higher for -842G-667T, P < 0.05, Fig. 2 ). These results were consistent with the association analysis between the haplotypes and NPC risk. Although the reporter gene expression activity of the variant -842C-667T was slightly higher than that of the wildtype -842G-667C, the statistical difference was insignificant (P > 0.05, Fig. 2 ).
Discussion
Inconsistent results were obtained from different studies on the association between PIN1 polymorphisms and cancer risk. Several studies showed that compared to -842GG homozygote, -842GC heterozygote conferred a reduced risk of cancer, including breast cancer in non-Hispanic white women 19 , squamous cell carcinoma of the head and neck 20 , lung cancer in Southern and Eastern Chinese populations 21 and NPC in Hunan Province of China 18 . However, from the data of a study on hepatocellular carcinoma, we inferred that -842GC heterozygote conferred an increased risk of cancer when compared to -842GG homozygote 20 . In this study, our finding showed that the -842GC and -842GC + CC offered a significantly increased risk of NPC in Guangdong Province populations. On the SNP -667C > T, most of the previous studies showed lack of statistical significance between genotype distribution and cancer risk. However, studies suggested that -667TT had a significantly increased risk of oral squamous cell carcinoma 22 and hepatocellular carcinoma 20 . These data were consistent with our study, indicating that -667TT genotype was associated with increased risk of NPC. The discrepancy among studies could be attributed to the different types of cancers, heterogeneous ethnic background and various sample size. Our larger sample size from high risky area of NPC in Guangdong Province provided representative and stable assessment for the genotype and allele frequencies of PIN1 promoter. A few studies have been reported to determine the association between cancer risk and PIN1 haplotypes. PIN1 haplotype -842C-667T was associated with decreased risk of squamous cell carcinoma of the head and neck compared to -842G-667T 23 . Haplotype -842C-667C was associated with reduced risk of esophageal carcinoma and lung cancer compared to -842G-667T 22, 24 . However, PIN1 haplotypes analysis in our study indicated that Table 2 . Genotype and allele distribution of -842G > C and -667C > T in patients and controls. a Data were calculated by unconditional logistic regression with adjustment for age and gender.
both -842G-667T and -842C-667C haplotype showed an increased risk of nasopharyngeal carcinoma compared to the -842G-667C haplotype.
Overexpression of PIN1 was found to enhance cancer growth and aggressiveness in NPC 17 . Functional analyses of the PIN1 promoter polymorphism with luciferase reporter assay were performed in our study. The result indicated that the transcription activity driven by the variant -842C-667C and -842G-667T were higher than those driven by the -842G-667C. The ratio of the transcription activity increasement of the two variant is consistent with the cancer risk ratio of corresponding haplotype. Our data showed lack of statistical significance between -842G > C and -667C > T genotype and clinicopathological parameters including age, gender, primary tumor extension, lymph node status and metastasis in patients. The data was similar to our previous study 18 and the study in breast cancer 25 . However, lack of statistical significance may be resulted from lack of clinicopathological information in some studies.
In conclusion, our study suggested that PIN1-842G > C (rs2233678) and -667C > T (rs2233679) polymorphisms were significantly associated with the risk of nasopharyngeal cancer in Guangdong Province, and the two SNPs might be a potential biomarker for cancer risk, especially for nasopharyngeal cancer. Diverse ethnic groups and further mechanistic studies of the different -842G > C and -667C > T variants are warranted to validate our findings.
Materials and Methods
Study population. The population based case-control study was conducted to assess the association of PIN1 polymorphisms with NPC susceptibility. The study population included 733 patients with nasopharyngeal carcinoma (NPC) and 895 healthy controls. Among them, a total of 336 patients with NPC and 895 controls were recruited at Affiliated Hospital of Guangdong Medical University (Zhanjiang, Guangdong Province, China) from September 2014 to October 2015. Another 397 patients with NPC were recruited at Nanfang hospital, Southern Medical University (Guangzhou, Guangdong Province, China) between July 2010 and December 2011. The patients were diagnosed by histopathology evidence and received no treatment before the blood drawing. The clinicopathological data including tumor size, nodal status and distant metastasis, clinically determined by computed tomography (CT) scan or magnetic resonance imaging (MRI), were available in only 235 patients (167 from Zhanjiang and 68 from Guangzhou). Controls were genetically unrelated cancer-free individuals matched with cases by age and gender. The mean ages of NPC patients and normal controls were 50.22 ± 15.91 and 47.05 ± 11.38, respectively. Informed consent was obtained from all participants. This study protocol was approved by the Ethics Committees of Guangdong Medical University.
Genotyping analysis. Genomic DNA was extracted from peripheral blood samples on the basis of standard procedures using TIANamp Genomic DNA kit (Tiangen Biotech, Beijing, China). The two SNPs (-842G > C rs2233678, and -667C > T rs2233679) were genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay as described previously 26 . Since the two SNPs are close in distance, we used same primer sequences: sense 5′-CGG GCT CTG CAG ACT CTA TT-3′ and antisense 5′-AAA TTT GGC TCC TCC ATC CT-3′. The PCR products were digested with two different enzymes to identify the respective genotypes. Ban II (New England BioLabs, Beverly, MA, USA) was used for rs2233678 or Sac I (New England BioLabs, Beverly, MA, USA) was used for rs2233679, at 37 °C for more than 4 h or overnight. After that, the cleaved products were separated on 3% agarose gel and identified by ethidium bromide staining. The sequences of PCR products were confirmed by DNA sequencing in about 10% of the samples which were randomly selected.
Construction of reporter plasmids. The pGL3 firefly luciferase reporter plasmids were constructed by Generay Biotech (Shanghai, China). The -842G/-667C reporter construct (wildtype promoter, namely -842G-667C) was prepared by amplifying the 1016 bp PIN1 promoter region (from −973 to +42 relative to the translation start site) and then ligating to the pGL3 basic vector (Promega, Madison, WI, USA). The -842C/-667C (namely -842C-667C), -842G/-667T (namely -842G-667T) and -842C/-667T (namely -842C-667T) reporter constructs were obtained from the -842G/-667C construct by site-directed mutagenesis. The reporter plasmids were confirmed by sequencing.
Transient transfection and luciferase assays. The human nasopharyngeal carcinoma cells (CNE2) were cultured in RPMI Medium 1640 basic supplemented with 10% Fetal Bovine Serum, maintained in a humidified with 5% CO 2 at 37 °C. Cells were seeded in 24-well tissue culture plates overnight for attachment before transfection and transfected using jetPEI ™ Polymer-based DNA transfection reagent (Polypus-Transfection Inc, New York, USA) according to the manufacturer's recommendations. Briefly, 1 μl of jetPEI ™ , 250 ng of firefly luciferase plasmid DNA (-842G-667C, -842G-667T, -842C-667C or -842C-667T), 2.5 ng of the pRL-TK vector (Renilla luciferase plasmid) was co-transfected as an internal control for transfection efficiency and diluted in 50 μl of NaCl (Polypus-Transfection Inc, New York, USA). Cells were incubated for 48 h after transfection. Luciferase activity was quantified by a Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA) using a FB12 luminometer (Titergek-Berthold, Pforzheim, Germany). Relative luciferase activity was calculated as a ratio of Firefly to Renilla signal intensity. The transfections were performed a minimum of three times, with samples in triplicate using different plasmid preparations for each transfection.
Statistical analysis. The Hardy-Weinberg equilibrium was utilized to compare the observed frequencies with the expected genotype frequencies in the control groups. The different distributions of the genotype and allele frequencies of PIN1 were evaluated by chi-square test. The associations between the two SNPs genotypes and the risk of nasopharyngeal carcinoma were estimated by calculating the odds ratio (OR) and 95% confidence interval (CI), using the multivariate logistic regression analysis adjusted by age and gender. To validate the robustness of the conclusions, the genotype and allele distribution of -842G > C and -667C > T in patients and controls were re-analyzed by monte carlo estimation, a resampling statistics method, using the nonparametric test with P value and corresponding 95% confidence interval [27] [28] [29] . The chi-square test or Fisher's exact test was performed in a subsequent analysis of the association between the genotype and clinicopathological characteristic in patients. We detected the two SNPs linkage disequilibrium (LD), analyzed haplotype frequencies between the two promoter variants and evaluated the association between the haplotype and nasopharyngeal carcinoma risk using SHEsis Online Version 30, 31 . Statistical analyses were performed with SPSS 16.0 software and P < 0.05 was considered to indicate statistical significance. Power analysis was performed in particular statistical test using PASS 11 software.
